Chapter 4 Targeting renin–angiotensin system a strategy for drug development against neurological disorders
Book chapter (January 2023)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
A synthetic BBB-permeable tripeptide GCF confers neuroprotection by increasing glycine in the ischemic brain
Article in Frontiers in Pharmacology (August 2022)
Adhesion of Leukocytes to Cerebral Venules Precedes Neuronal Cell Death and Is Sufficient to Trigger Tissue Damage After Cerebral Ischemia
Article in Frontiers in Neurology (January 2022)